Stay updated with breaking news from Gerard Pasterkamp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Leducq Foundation has awarded $15 million to researchers at UVA Health and their collaborators to advance our understanding of atherosclerosis, or hardening of the arteries, and find better ways to treat it. Diseases linked to atherosclerosis are the leading cause of death in the United States.
The Boston-based LeDucq Foundation has awarded $15 million to researchers at UVA Health and their collaborators to advance our understanding of atherosclerosis, or hardening of the arteries, and find better ways to treat it.
A new study identifies a new group of stroke patients for whom more aggressive secondary preventative therapy may be required.
The CAPIAS trial suggests that substenotic plaque on MRI may play more of a role in ischemic stroke than previously thought.
E-Mail IMAGE: Researcher Mete Civelek, PhD, of the University of Virginia School of Medicine's Department of Biomedical Engineering and UVA's Center for Public Health Genomics. view more Credit: Courtesy Civelek lab Researchers at the University of Virginia have shed light on how our genes affect our risk for coronary artery disease, the most common form of heart disease. In addition to identifying gene variants that influence risk, they found that one gene in particular appears to have a protective effect. Doctors may be able to use the findings to identify people at high risk ...